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We enter the 21st century with an impressive
therapeutic armamentarium for addressing vascular
diseases. With this capacity comes a societal impera-
tive that we use the tools wisely. In many cases, we
are fortunate to have a variety of means available to
treat a specific vascular problem. Our challenge is to
make a wise choice among alternative therapies by
examining the results that each is likely to produce.
Many of the treatments available to us are costly.
Therefore, it is critical to understand the relative
value of treatments through examination of the
costs, risks, and benefits associated with each.
Potential delivery systems are in fierce price compe-
tition with each other. In settings in which prices
and benefits are comparable, the patients’ perspec-
tive on quality of care becomes the determining fac-
tor in choices among delivery systems. The increas-
ing sophistication of our patients also means that we
will predictably be asked what a patient can expect to
happen under a variety of treatment scenarios. All of
these forces, pressing powerfully on us, dictate that
we systematically broaden our capacity to evaluate
the results of the care that we deliver.
This article examines the dimensions into which
we might broaden our assessment of clinical out-
comes. The topic is important to clinical vascular spe-
cialists, who want to improve patient care and quali-
fy for reimbursement; to practitioner groups and
practice plans, who need to demonstrate the value of
their care to contracting payers and for accreditation
purposes; to researchers, as they conduct and evalu-
ate the results of clinical trials; and to designers of
public policy, who wish to maximize the good that
comes from medical care and minimize its cost.
There are numerous ways of conceptualizing the
many dimensions of health care. Most conceptual-
izations agree, however, that there are more dimen-
sions than simply the clinical or physiologic response
of the target disease to the treatment offered. Other
dimensions include the costs of treatment, the func-
tion and well-being of patients, and patients’ satis-
faction with the care that they receive,1-4 as well as
their priorities and preferences for particular out-
comes. Assessing these additional dimensions of a
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health care intervention is what we mean by extend-
ed outcome assessment in this article.
DIMENSIONS OF EXTENDED OUTCOME
ASSESSMENT
Clinical status. Within the conceptual framework
just described, clinical status measures most closely
correspond to outcomes that we are presently used to
measuring. These might include morbidity, mortality,
graft patency, complications, and laboratory test
results. Many of these measures have been clearly
defined and recommended for general use by the Ad
Hoc Committee on Reporting Standards of the joint
council of the Society for Vascular Surgery and the
International Society for Cardiovascular Surgery,
North American Chapter (SVS/ISCVS-NA).5-10
Cost. The value of health care can be conceptu-
alized as a function of quality, volume, and cost:
value = quality × volume/cost.1
The public’s desire that physicians be account-
able for the value of medical care offered means that
we must be able to measure the cost of that care in
an appropriate way. Currently, the vascular surgery
literature rarely reports costs.11
Exactly which costs should be measured depends
entirely on the frame of reference. If, for example,
the central question is personal cost from a patient’s
perspective, then out-of-pocket costs and time lost
from the patient’s usual activities might be appropri-
ate and sufficient measures of cost. If the perspective
is that of a provider, then actual costs of providing
care become appropriate to measure. Societal costs at
large are perhaps the most difficult to assess, inas-
much as arriving at estimates of these requires mea-
surement of costs from differing perspectives—those
of the patient, the provider, the payer, and the com-
munity (eg, net productive work time gained or lost
because of the care). A complete description of meth-
ods for determining costs in medical care is beyond
the scope of this review, but the topic is important.12
Functional status. Clinical measures such as mor-
bidity, mortality, graft patency, complications, and lab-
oratory test results are excellent ways by which to
judge technical procedural success. However, it has
become increasingly evident in other medical special-
ties, as well as in our own, that clinical measures may
correlate poorly with patients’ day-to-day function or
with their perceptions of their health status. In benign
prostatic hyperplasia, for example, objective measures
(uroflometry, postvoid residual, prostate size, and
degree of bladder trabeculation) do not correlate with
patient-reported symptom severity.13 After total knee
replacement, radiologic characteristics do not correlate
with functional outcome.14,15 Many vascular surgeons
are surprised to learn how poor the correlation is
between ankle-brachial index and walking ability.16,17
This lack of correlation between hemodynamic and
functional measures of success means that we must
measure functional health itself (and not use clinical
measures as proxies) if we are to achieve a full under-
standing of the results of health care.
Functional health status measures help quantify
how symptoms affect aspects of everyday life. This
extension of measurement addresses the World
Health Organization’s charter definition of health:
“a state of complete physical, mental, and social
well-being and not merely the absence of disease or
infirmity.”18 In addition, inclusion of such measures
brings us closer to understanding the net value of a
health care intervention and to being able to fully
understand patients’ experiences of these interven-
tions. In this sense, functional status measures can
include global descriptors of “quality of life” but can
also be more specific. Specific dimensions, such as
physical and mental well-being, pain, ability to carry
out desired activities, sleep, energy or vitality, and
global self-estimation of health, are often assessed in
this area. These are dimensions that pertain to all
patients, and instruments that aim at broadly evalu-
ating all of these dimensions are usually referred to
as generic functional health assessment instruments.
The most widely used generic functional health
assessment instruments are listed in Table I.
Frequently, disease-specific functional health
assessment instruments are also used, so that func-
tions impacted by the disease in question can be
examined in finer detail. Table II details the reasons
for which one might wish to use generic and disease-
specific functional health assessment instruments.
Usually, when a group of patients is being surveyed,
a generic instrument and a disease-specific instru-
ment are used together, because each yields impor-
tant information. Currently, the Walking Impairment
Questionnaire (WIQ) is most commonly used for
detailed assessment of patients with lower extremity
arterial occlusive disease.19
Information regarding a patient’s functional sta-
tus is typically obtained by survey, which either is
conducted by an interviewer or is self-administered.
Some vascular surgeons have questioned the validity
of using subjective information as an outcome mea-
sure. In many ways, as noted at the outset of this
article, patients’ opinions are a driving force in med-
ical decision making; after all, patients are the con-
sumers of our interventions, and only they can know
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how the interventions affect their daily lives.
Outcome is subjective from a patient’s perspective.
If we follow the tenets of survey research and keep
in mind that global outcome assessment requires
blending clinical information with function, cost,
and satisfaction outcome information, some of the
concerns about using subjective information as an
outcome measure may be allayed. Table III summa-
rizes the attributes of a useful survey instrument.
Potential sources of bias are legion in subjective
outcome reporting. A relative, a caregiver, or some-
one else who completes a survey on behalf of a
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Table I. Commonly used generic functional health assessment instruments
Instrument Concepts measured Scoring Advantages Disadvantages
SF-3641-43 General health Health profile Broadly validated worldwide Lengthy
perceptions, health (by concept) Translated into Requires scoring conversion
transition (1 y) or physical component several languages for reporting
Social function summary/mental Independent subscale scores
Physical function component summary Frequently used in PAD patients
Role (physical) (not value-adjusted) Can be used to track patient
Mental health progress without score conversion
Role (emotional)
Pain
Vitality
EuroQol Mobility Health profile Translated into several languages Not widely used in the US
(EQ-5D)44 Self-care or health index Broadly validated in Europe Some questions may be too
Main activity (based on population- Excellent test-retest reliability broad to allow assessments
Social function derived values) Small number of dimensions of specific treatments
Pain allows for easier interpretation Visual analog scale not
Mood Frequently used in PAD patients commonly encountered
by patients
COOP/ Physical fitness Health profile Pictures simplify questions Some examples may be
WONCA Feelings Visual images allow physicians confusing
charts45,46 Daily activities to scan forms quickly Not widely used outside
Social activities psychosocial setting
Pain
Health change (2 wk)
Overall health
Nottingham Energy Health profile Translated into several languages Lengthy
Health Emotional reactions Broadly validated in Europe
Profile47 Sleep
Social isolation
Pain
Physical mobility
Functional Physical function Health profile Useful to assess disability caused Complex score conversion
Status Psychological function by disease Not widely used in PAD
Questionnaire48 Role function Brief patients
Social function Excellent internal consistency
Bed/restricted days
Sexual relationship
Health perception
Quality of Mobility Health index or Single score to indicate quality Not widely used in PAD 
Well-Being Physical function health profile or of well-being patients
Scale49 Social activity physical/mental
summary scores
Sickness Sleep and rest Health profile or Most comprehensive and detailed Not widely used outside the US
Impact Emotional behavior physical/psychosocial inventory in common use Calculation of summary score
Profile50 Body care and dimension scores Excellent test-retest reliability may be difficult
movement or overall score Provides overall assessment of Lengthy
Home management (not value-adjusted) impact of comorbid conditions
Mobility Has been used to assess
Social interaction PAD patients
Ambulation
Alertness behavior
Communication
Work
Recreation and pastimes
Eating
PAD, Peripheral arterial disease; US, United States.
patient may overestimate or underestimate the
patient’s performance in a given area.20 Subtle
changes in intonation, phrasing, or prompting may
influence a patient’s response if the questions are
posed aloud rather than in writing, and proper train-
ing of those who administer verbal surveys aims at
minimizing such effects. Involved parties, such as
attending surgeons, who seek feedback that they can
link to individual patients can expect to receive
unduly positive responses as the patients try to
please (or spare the feelings of) their physicians. The
careful evaluator of survey findings will be watchful
for such sources of biased information.
Despite concerns about bias, patients’ reports of
their functional health appear to have good face
validity in populations with diseases treated by vascu-
lar physicians and surgeons. Patients with hemody-
namically severe lower extremity arterial occlusive
disease have more bodily pain and worse physical
function than patients with mild disease,20 patients
with severe strokes have worse physical and role func-
tion and worse general health than patients with mild
strokes,21 and patients with venous ulcers have
impaired social interaction, domestic activities, and
emotional status.22 Patients with vascular diseases
also report that clinically successful therapy improves
their function in these dimensions. Hemodynami-
cally successful revascularization for lower extremity
arterial occlusive disease lessens bodily pain and
improves physical function and mobility.17,23-25
Healing of venous ulcers is also associated with func-
tional health improvement.22 Observations such as
these, which are appearing with increasing frequency
in the vascular literature, speak strongly to the role of
subjective reporting in the evaluation of the results of
care for vascular diseases.
In the United States, the most commonly used
validated generic functional health assessment instru-
ment is the Medical Outcomes Study (MOS ) short-
form 36 (SF-36). Answers given by patients to these
36 questions can describe patient function in physical
and social spheres, role limitations due to physical
health problems or emotional problems, and patient
perceptions of general health as well as bodily pain,
mental health, and vitality. In addition, the SF-36
evaluates patient perception of change in health over
the past year. Thus, the SF-36 combines elements of
the functional status questionnaire and the quality of
life questionnaire. Answers are typically scored on a
scale from 0 (poorest) to 100 (best). Because so
many people with defined characteristics have
responded to this questionnaire, a patient’s scores
can be normalized and reported in comparison with
the scores for a general population or a population
with defined characteristics. In this case, the distribu-
tion of scores in the comparison population is report-
ed with a mean of 50 and an SD of 10; the patient’s
score is reported on the normalized scale.26 Table IV
reproduces the questions of the SF-36.
Surgeons might wonder what value the measure-
ment of generic functional health has for their patients.
The accumulation and analysis of a vast amount of
functional data from patients responding to the SF-36
have revealed that there is much practical and prog-
nostic information to be gleaned from patients’ scores.
For example, a patient with a raw score (not normal-
ized) of less than 80 on the bodily pain scale has a
greater than 50% chance of having pain interfere with
normal work; virtually all patients scoring less than 50
on this scale report that pain interferes to a moderate
or extreme extent with normal work. As a corollary,
improvement from a score of 50 to a score of 60 on
this scale is associated with marked decrease (from 37%
to 8%) in the likelihood that pain will interfere signifi-
cantly with normal work.27
The prognostic information associated with SF-
36 scores is also of interest. For example, the annu-
al medical expenditures of Medicare patients who in
1995 rated their own health as “poor” averaged
$12,000, whereas the comparable figure for patients
who rated their health as “fair” (the next best possi-
ble rating) was one half of that amount.28 The phys-
ical health summary score (a composite of responses
to questions concerning physical function, pain,
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Table II. Pros and cons of using generic and disease-specific instruments to assess functional health
Generic instruments Disease-specific instruments
Pro Con Pro Con
Many already validated Not sensitive to some clinically Useful instruments are sensitive Can’t compare findings across
Widely available important changes to clinically important changes populations
Allows comparison of health Already developed and well
status across groups validated only in certain disease
categories
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general health, vitality, and social function) is linear-
ly related to job loss at 1 year and to mortality at 5
years.29 The latter relationship is of particular inter-
est: if the summary score is less than 35, 5-year mor-
tality is 17.3%; if it is greater than 55, 5-year mortal-
ity is only 1.8%.
In what way might functional health assessment
be relevant to patients with vascular disease?
Relevance is most easily seen in assessing the value of
interventions for symptomatic conditions such as
claudication or ischemic rest pain. In this case, the
principal aim of an intervention is to relieve the tar-
get symptoms. Technical/clinical success of the inter-
vention (in this case, patency of the segment under-
going intervention) is usually the sine qua non of
functional success. However, functional measures go
beyond the technical/clinical measures, both to ask
whether the underlying symptoms—in these exam-
ples, walking disability and lower extremity pain—
have been relieved and to help assess what the over-
all effect of the intervention has been on a patient’s
ability to function in his or her daily life away from
the medical care setting. Has the intervention had
unintended outcomes with regard to overall pain,
ability to carry out household chores, interaction
with others, and feelings of vitality and optimism?
Incisional pain, lower extremity edema, depression,
and discouragement might conceivably affect all of
these important functions and negate the clinical
value of a procedure (eg, revascularization for claudi-
cation, surgery for venous insufficiency) in the eyes
of an individual patient. Our current technically ori-
ented outcome measurement standards give us few
tools to use in assessing these important outcomes.
The relevance of functional health assessment to
asymptomatic patients undergoing interventions
aimed at averting possible catastrophe (eg, aneurysm
surgery, carotid endarterectomy for asymptomatic
disease) is also readily seen. What are the functional
trade-offs of intervention in the asymptomatic state?
Table III. Attributes of a useful survey assessing functional health
Technical concept
Reliability
Content validity
Concept validity
Construct validity
Responsiveness to 
change
Acceptability
Meaning
Extent to which results from
a given individual will
remain the same in the
absence of clinical
change, as well as the
extent to which similar
questions produce similar
responses
Extent to which the survey
measures what it intends
to measure
Extent to which the survey
response accurately
reflects an objectively
measurable, real-world
condition, either concur-
rent or future
Same as concept validity,
except that objective mea-
sure of the condition does
not exist
Clinically meaningful change
is measurable by the
instrument
Instrument is not too bur-
densome for patients or
staff and is feasible for use
in the intended setting
Questions to ask
Are responses reproducible
in the absence of a
change in health status?
Do respondents give simi-
lar responses to ques-
tions about similar con-
cepts?
Do questions in the survey
address all of the issues
that are important in
defining the concept at
hand (ie, all health
effects of the disease in
question)?
Is there a measurable gold
standard for this con-
cept, and has it been
compared with the
responses?
Does the result of the
measure in question
correspond logically to
other measures of the
same idea?
When patients feel they are
improved, is this reflect-
ed in the appropriate
score?
How do patients and staff
feel about completing
the questionnaire?
Examples
Stable patients with intermittent claudication have
responded to the questionnaire on 2 separate days
approximately 1 week apart and indicated the
same level of function on both questionnaires.
Patient focus groups consisting of claudicants have
identified all of the areas of function addressed
by the questionnaire as being the ones impacted
by their condition.
Ischemic rest pain is reported more often by sub-
jects with poor foot perfusion by objective mea-
sures than by those with good foot perfusion.
Patients reporting ischemic rest pain experience
a higher frequency of subsequent limb loss than
those not reporting such pain.
A patient who is reporting impaired walking ability
also reports difficulty doing house and yard
chores.
The functional status assessment instrument is suc-
cessful in detecting the preprocedural-to-post-
procedural difference in walking ability of a
patient undergoing a technically successful
angioplasty of a sole, isolated iliac stenosis.
The questionnaire has been used for repetitive
functional status assessment and patients report
that they would not mind completing the ques-
tionnaire on future visit(s).
Are they worse than the looming catastrophe? Does
intervention relieve or cause anxiety about an identi-
fied risk? Currently, we are not meeting the patients’
need for us to assess these unintended consequences
and be able to provide answers when they ask what
daily life might be like after proposed interventions.
Having patient-derived functional health information
will probably not change the operations that we per-
form to avert life-threatening catastrophes, but it will
improve our understanding of the consequences for
patients and allow us to improve our systems of care
to lessen the adverse impact of these procedures.
Satisfaction. Assessment of patient satisfaction
with medical care is an ongoing challenge. Individual
practices and providers or organizations have circu-
lated many different patient satisfaction surveys
thought to be suited to their individual needs.
Managed-care plans are increasingly required to
assess themselves using more widely adopted satisfac-
tion measures, such as those from the Health Plan
Employer Data and Information Set.30 In general,
these measures of satisfaction are generic and focus
on access to providers, courtesy and respect shown to
patients, satisfaction with the physical setting where
care is delivered, waiting times, and provider/staff
communication skills. These are undoubtedly impor-
tant aspects of the patient’s encounter with the med-
ical system. However, in surgical care, in which there
is an identifiable intervention occurring as a discrete
episode, other dimensions may be equally or more
important. These dimensions are largely unexplored,
but they might include some or all of the following:
perceived health benefit of the operation or proce-
dure, patient perception of surgeon competence,
patient understanding of what could happen, and
ability of the surgeon and/or system to address the
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Table IV. Concepts and questions of Medical Outcomes SF-3629,51
Concept
Physical func-
tioning
Role: Physical
Role: Emotional
Social function–
ing
Component summary
score to which concept
maps
physical
physical
mental
mental
Question
The following items are about activities you might do during a typical
day. Does your health now limit you in these activities? If so, how
much? (Mark one oval on each line.)
Vigorous activities, such as running, lifting heavy objects, participating in
strenuous sports
Moderate activities, such as moving a table, pushing a vacuum cleaner,
bowling, playing golf
Lifting or carrying groceries
Climbing several flights of stairs
Climbing one flight of stairs
Bending, kneeling, or stooping
Walking more than a mile
Walking several blocks
Walking one single block
Bathing or dressing yourself
During the past 4 weeks, have you had any of the following problems
with your work or other regular daily activities as a result of your
physical health? (Mark one oval on each line.)
Cut down on the amount of time you spent on work or other activities
Accomplished less than you would like
Were limited in the kind of work or other activities
Had difficulty performing the work or other activities (for example, it
took extra effort)
During the past 4 weeks, have you had any of the following problems
with your work or other regular daily activities as a result of any
emotional problems (such as feeling depressed or anxious)? (Mark
one oval on each line.)
Cut down on the amount of time you spent on work or other activities
Accomplished less than you would like
Didn’t do work or other activities as carefully as usual
During the past 4 weeks, to what extent has your physical health or emo-
tional problems interfered with your normal social activities with family,
friends, neighbors, or groups? (Mark one oval)
During the past 4 weeks, how much of the time has your physical health
or emotional problems interfered with your social activities (like visit-
ing with friends, relatives, etc)? (Mark one oval)
Responses
Yes, Limited A Lot;
Yes, Limited A
Little; No, Not
Limited At All
Yes; No
Yes; No
Not at all; Slightly;
Moderately;
Quite a bit;
Extremely
Table continued on next pageThis questionnaire is not presented here in the format in which it should be administered.
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patient’s fears and provide information on what the
patient could do to hasten recovery.
Patient preferences. The value a patient places on
a specific health state may have an important influence
on the choice that he or she makes among therapeutic
alternatives. Achieving a better understanding of
patients’ preferences for various specific health states is
an important goal of extended outcome assessment.
With an understanding of patients’ values, two types of
analysis can inform our choices among alternatives.31
In quantitative decision analysis (also known as expect-
ed value decision making), the likelihood of a specific
clinical result is multiplied by the patient-derived value
of the result to determine the relative expected values
(on either an individual-patient basis or a population
basis) of therapeutic alternatives. Cost-effectiveness
analysis, more often done on a population basis for
public policy purposes, determines the net benefit per
net unit cost of an intervention. Population-derived
preferences are used to define the net benefit, often
expressed in quality-adjusted life years (QALYs), such
a unit being equal to the fraction of a year in perfect
health that the patient believes to be equivalent in
value to a year in the health state in question.31
Table V outlines the domains of extended out-
come assessment, the methods by which these
domains are typically measured, and the uses that are
typically made of information in each domain.
Table IV, cont’d. Concepts and questions of Medical Outcomes SF-3629,51
Concept
Component summary
score to which concept
maps Question Responses
The questionnaire is not presented here in the format in which it should be administered.
Bodily pain
Mental Health
Vitality
General health 
perceptions
Change in 
Health
physical
mental
mental
physical
How much bodily pain have you had during the past 4 weeks? (Mark
one oval.)
During the past 4 weeks, how much did pain interfere with your nor-
mal work including both work outside the home and housework?
(Mark one oval)
These questions are about how you feel and how things have been with you
during the past 4 weeks. For each question, please give the one answer
that comes closest to the way you have been feeling. How much of the
time during the past 4 weeks . . . (Mark one oval)
Have you been a very nervous person?
Have you felt so down in the dumps nothing could cheer you up?
Have you felt calm and peaceful?
Have you felt downhearted and blue?
Have you been a happy person?
These questions are about how you feel and how things have been with you
during the past 4 weeks. For each question, please give the one answer
that comes closest to the way you have been feeling. How much of the
time during the past 4 weeks . . . (Mark one oval)
Did you feel full of pep?
Did you have a lot of energy?
Did you feel worn out?
Did you feel tired?
In general, would you say that your health is:
Please choose the answer that best describes how true or false each of
the following statements is for you. (Mark one oval on each line).
I seem to get sick a little easier than other people
I am as healthy as anybody I know
I expect my health to get worse
My health is excellent
Compared to 1 year ago, how would you rate your health in general now?
None; Very mild;
Mild; Moderate;
Severe; Very severe
Not at all; A little bit;
Moderately; Quite
a bit; Extremely
All of the time;
Most of the
Time; A Good
Bit of the Time;
Some of the
Time; A Little of
the Time; None
of the Time
All of the Time;
Most of the
Time; A Good
Bit of the Time;
Some of the
Time; A Little of
the Time; None
of the Time
Excellent; Very
good; Good;
Fair; Poor
Definitely True;
Mostly True;
Not Sure;
Mostly False;
Definitely False
Much better than 1
year ago;
Somewhat better
than 1 year ago;
About the same;
Somewhat worse
than 1 year ago;
Much worse
than 1 year ago
PRACTICAL AND OPERATIONAL ISSUES
IN ASSESSING EXTENDED OUTCOMES
Why should vascular physicians and surgeons
assess extended outcomes? From a theoretical view-
point, extended outcome assessment should enable us
to reach several goals, including the following: (1)
achieving a more complete understanding of the effec-
tiveness of different interventions; (2) giving physi-
cians, payers, and patients the information that they
need to make better decisions; and (3) developing
standards to aid physicians, public policy makers, and
third-party payers in optimizing the use of resources.
However, acquiring more data pertaining to the out-
comes of specific interventions may by viewed by prac-
ticing vascular clinicians as a costly and time-consum-
ing venture with limited return. Many of us believe
that we already follow best medical practices and that
our patients have good medical outcomes. However,
there are significant benefits of outcomes assessment
that will reward the expenditure of effort.
One benefit of pursuing such a course might
simply be that it fulfills the expectations that society
has for us. Medicine is one of the three learned pro-
fessions, and part of the definition of a profession is
“a vocation in which a professed knowledge of learn-
ing or science is used in its application to the affairs
of others.”32 As detailed in this article, it is now
accepted that there are many dimensions of the out-
comes of our interventions. It is imperative that we,
as members of our profession, assess these extended
outcomes and apply our findings to the “affairs”
(lives) of our patients.
Another benefit of the course outlined above is
of a practical nature. Medicine is a service industry,
and we, as providers, should meet the needs of our
customers. Currently, patients as well as payers are
demanding more detailed assessments of the out-
comes of procedures so that they can make informed
decisions. Payers are more likely to pay for proce-
dures from which patients clearly perceive that they
have derived benefit.
We are in an era of medical cost containment,
and this will continue for the foreseeable future.
This implies that using medical resources for proce-
dures with limited to no overall benefit decreases
our ability to offer services that are clearly beneficial.
Extended outcomes assessment provides the data
that will allow us to be more confident in the wis-
dom of our use of resources for medical treatments
and ensure that we will deliver the most appropriate,
cost-effective, and medically effective care.
By taking the lead in assessing extended outcomes,
we will take more effective control of our professional
future. The Task Force on Competence of the
American Board of Medical Specialists is reworking its
concepts of appropriate criteria for maintenance of cer-
tification for medical specialists. One of the criteria in
the preliminary draft versions dealing with these con-
cepts is “evidence of satisfactory practice perfor-
mance.” This clearly means that we must know, in
detail, the outcomes of our interventions. Several gov-
ernment and private agencies have already launched
programs directed at determining the effectiveness of
medical interventions. It is highly probable that they
will use this information for the development of
national guidelines for medical practice. The dimen-
sions in which they determine effectiveness may or
may not be clinically appropriate, but if we do not have
data with which to support alternative interpretations,
these agencies will define effectiveness without us and
determine for us what care is appropriate as well as
where resources will be allocated.
What’s in extended outcomes assessment for vas-
cular surgeons and physicians? Simply put, wise
assessment of an extended set of outcomes will allow
optimal decisions for all parties involved.
Is the measurement of extended outcomes a
research tool or an aid in an individual practice?
Prediction rules, allocation decisions, and population
health can all be made or described on the basis of
outcome assessment in a research setting. Many may
wonder, therefore, why individual physicians should
trouble to measure functional health or other dimen-
sions of extended outcome in their own practices.
We strongly believe that there are many reasons
why data obtained in research settings or in other
practices may not be sufficient for optimization of
the care of individual patients. Chief among these is
the individuality of patients and their concerns. The
extreme contrast between one patient who experi-
ences terrible emotional distress when confronted
with the knowledge of an asymptomatic but poten-
tially life-altering condition and another patient who
is much more phlegmatic is known to all vascular sur-
geons, and each of us has used such information to
optimize the timing for repair of an abdominal aortic
aneurysm. Not all such feelings are as well sought out
by or communicated to physicians, however. In the
geriatric general practice experience, assessment of
functional health status in conjunction with every
visit improves care both in patients’ eyes and as
judged by external standards.33 Having patient-
specific information readily available at the time of a
clinical encounter makes for the best opportunity to
optimize the care that is offered to the patient.
How does one get started? The primary purpose
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sensus on the measures that yield the most informa-
tion about patients with vascular diseases. In the inter-
im, it is easiest to use published measures that are
aimed at assessing the problems that vascular patients
are likely to have, are sensitive to clinically important
change and reproducible in the absence of clinical
change, and involve the asking of questions that are
understood in the same way by a broad variety of
patients (ie, questions that have been “validated”).34
If these measures can be scored easily and the data can
be entered directly by patients into the analyzing
computer, so much the better. For these reasons, and
for the other reasons cited above, a logical first step
might be to assess patients’ responses to the SF-36
over time. The SF-36 is easy to obtain and is free to
use for personal or organizational noncommercial
purposes as long as permission has been obtained
from the developer.35 As previously noted, preferred
scoring algorithms have changed over time as a larger
database of responses from patients of different ages
and defined comorbid conditions and diseases has
been accumulated. Electronic scoring algorithms,
available commercially, greatly simplify the task of
comparing a patient or population to other defined
populations (such as healthy Americans of the same
age and sex). Printed tables of norms for specific
patient populations are also available.29,36
Readers new to the field of functional health assess-
ment frequently wonder how much change in an SF-
36 score might be generally thought to be clinically
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of taking the initiative to assess extended outcomes is
to improve them over time. The first, and perhaps
most difficult, task in starting on the venture is to be
realistic and relentlessly practical in understanding
which characteristics of your practice might benefit
most from change. This dictates the highest priorities
for data collection and helps to streamline the number
and types of questions that you pose to patients and
the data that you subsequently aggregate and analyze.
No program will be perfect at its outset, and it is
important to be reassured that all outcome assessment
programs evolve over time, both because of increasing
expertise and because of changing goals. The most
important step to take is to begin.
Following the characterization of the dimensions
of extended outcome assessment discussed above,
one might evaluate one or two elements of each area
(clinical status, cost, functional status, satisfaction,
and preferences). Useful measures of clinical status
have been well characterized in the publications of
the Ad Hoc Committee on Reporting Standards of
the joint council of the SVS/ISCVS-NA.5-10
As noted, the choice of appropriate measures of
cost is dictated by the specific question that the
assessor wishes to answer. Because of their complex-
ity, cost considerations are frequently omitted from
an initial attempt to measure extended outcomes.
Assessment of functional status is more problem-
atic at present. As our specialties’ collective expertise
in assessing these areas increases, we may reach con-
Table V. Extended outcome assessment at a glance
Outcome
dimension assessed Meaning How measured Typical uses
Clinical Physiologic response to Signs/symptoms Assessment of care effectiveness,
disease/treatment Mortality technical quality
Graft patency
Complications
Test results
Cost Monetary cost Perspectives vary Cost-effectiveness analysis
Cost/charge ratio
Cost accounting
Relative value units
Functional How symptoms/treatment By survey, usually completed Prediction for patients
health affect aspects of everyday life by patient Cost-effectiveness analysis
Typical domains: physical function,
mental health, social function,
role function, sleep, energy, sexual
function, general health perception
Satisfaction Patient’s feelings about By patient survey (eg, HEDIS30) Clinical redesign
an episode of health care Marketing
Utilities How patients or populations value Time tradeoff Decision analysis
life in given specified health state(s) Standard gamble31
HEDIS, Health Plan Employer Data and Information Set.
significant. The answer to this question depends on
the variability in the underlying population. One gen-
eral way to assess whether a treated population is dif-
ferent from an untreated or comparison population is
to calculate the effect size (ratio between the means or
medians of the two groups and the SD or interquartile
range of the same two populations).37 Combining the
use of electronic data entry by patients and the con-
cepts of item response theory may allow researchers to
estimate an individual’s functional health in a given
area with far greater precision than in the past, there-
by making it quicker and easier to assess the effective-
ness of clinical treatments over time.38 The power of
this concept is exemplified by the rapidity with which
the general mental health of a middle-aged, chronical-
ly ill person can be assessed with enough precision to
flag positivity of a depression screen. Formerly, this
would have required that the patient respond to 31
questions; now, use of the dynamic technique reduces
the number of questions to two to four, with an asso-
ciated reduction of 80% to 90% of the time required.39
Functional health assessment tools specific for
vascular diseases are increasingly available19,22 and
help to allow more detailed and clinically relevant
functional health assessment. Increasing experience
with these instruments may someday allow the estab-
lishment of expected norms for a given population.
Finally, measures of patient satisfaction and pref-
erence may be incorporated into an extended out-
come assessment. These, however, are the least well
standardized of measures of the different dimensions
in extended outcome assessment. Satisfaction with
surgical care has not been well explored, so one
might be tempted to incorporate generic measures
of satisfaction with health care.30 Although several
methods have been developed and used for assessing
patient preferences,31 these are cumbersome and not
easily compacted, though adaptation to patient
entry by computer has been achieved.40
The best method for collecting and analyzing the
data depends on local resources and personnel.
Paper questionnaires require data aggregation, usu-
ally by secondary entry into a computer. Bar coding
and scanning technology require somewhat less
work but involve a greater investment in hardware.
Having patients respond to the questions electroni-
cally, either through use of freestanding office com-
puters or through the Internet, increases the ease of
data aggregation but also the requirement for tech-
nical sophistication. Partially customizable but com-
mercially available outcome tracking programs may
represent a good investment for some practices.
Is extended outcome measurement necessarily
more time-consuming and costly than current prac-
tice? Presently, members of our profession tend to
accumulate dissimilar data elements in various for-
mats, both paper and electronic, for purposes of
clinical notation, billing, and outcome assessment.
Inefficiencies of parallel data collection and report-
ing systems are the rule rather than the exception. 
Is it possible to imagine that more complete and
more useful data collection could be accomplished?
We believe that with the aid of advances in
patient/provider and electronic sophistication, such
improvement is possible. Patients are increasingly able
to respond electronically, either in the office or
through the Internet, to surveys such as those used to
quantitate functional health and assess patient satisfac-
tion. Such electronic response largely obviates data
reentry by other people and provides data for immedi-
ate computer generation of clinical chart notes. By
engaging in extended outcome assessment, we might
be able to have more complete patient-derived data
available to us in real time to help with clinical care
while spending less time in documentation.
Is there a prescribed set of outcome measures?
To advocate a mandatory set of “outcome mea-
sures” would be both presumptuous and unproduc-
tive, inasmuch as each improvement to be made or
question to be answered has a different spectrum of
specific priorities. However, many of us are per-
forming similar procedures (such as revasculariza-
tion for limb threat) and are asking questions from
similar perspectives (such as those of our individual
practices). By analogy to the achievements of the Ad
Hoc Committee on Reporting Standards of the joint
council of the SVS/ISCVS-NA, achieving consen-
sus on measures that are to be used for evaluating
similar concepts in an extended outcome measure-
ment scheme would represent a significant advance
in our field. Doing this would facilitate discussions
in a common language about an extended set of out-
comes of procedures for vascular conditions, facili-
tate rapid comparisons among patient groups or spe-
cific interventions, and thereby make improvement
in clinical care as rapid as possible. This is the kind of
accountability that we owe our patients.
A VISION FOR THE 21ST CENTURY
In summary, our next task is to have the data that
we need available in real time so that we can answer
the questions of patients, practitioners, and payers
and planners—respectively, “What is likely to hap-
pen to me if we pursue alternate strategy a, b, or c?”
“How am I doing in treating condition x?” and
“What is the value of specific therapies for defined
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populations?” We can take a first step in this direc-
tion by working together in the effort to reach con-
sensus about which extended measures of procedur-
al outcome we will use.
The Committee wishes to thank John D. Birkmeyer,
MD, and the members of the Dartmouth Surgical
Outcomes Assessment Group for their critical review of
and input to this article.
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